This means insulin release occurs primarily when blood sugar is elevated, reducing the risk of hypoglycaemia compared to some other diabetes medications
Syzygium zeylanicum (L.) DC
Antibodies against phosphorylated IR (p-IR)/IGF1R (catalog 3024), IR (catalog 3025), IGF1R (catalog 3027), -actin (catalog 4970), GAPDH (catalog 5174), p-AKT S473 (catalog 4060), AKT pan (catalog 4685), p-ERK1/2 T202/Y204 (catalog 4370), ERK1/2 (catalog 9102), p-Shc Y239/240 (catalog 2434), Shc (catalog 2432), p-Gab-1 Y627 (catalog 3233), Gab-1 (catalog 3232), p-mTOR S2481 (catalog 2974), mTOR (catalog 2972), p-c-Jun S73 (catalog 3270), c-Jun (catalog 9165), p- p-S6 S235/236 (catalog 2211), S6 (catalog 2217), p-JNK T183/Y185 (catalog 4668), and JNK (catalog 9252) were purchased from Cell Signaling Technology

doi: 10.3389/fonc.2026.1680441 Received 06 August 2025 Revised 20 January 2026 Accepted 20 January 2026 Published 03 February 2026 Volume 16 - 2026 Edited by Arumugam Jayakumar, University of Texas MD Anderson Cancer Center, United States Reviewed by Enrico Martin, University Medical Center Utrecht, Netherlands Fei Song, Affiliated Hospital of Nantong University, China Updates Copyright 2026 Zhu, Shen, Yang, Han, Li, Xie, Tan, Lu, Ji and Zhang